Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Graves' Disease I: Introduction

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

Hypothyroidism II: Pathophysiology

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

The Thyroid Gland

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Serum adipocytokine levels in patients with renal cell carcinoma.

Endokrynologia Polska·2026

Same author

Lipidogram profiles in patients with Graves' and Basedow's disease with and without orbitopathy.

Endokrynologia Polska·2026

Same author

Is vitamin D deficiency a risk factor for obesity-related morbidity, prediabetes, and type 2 diabetes - a literature review and proposals from the experts of the Polish Society of Endocrinology.

Endokrynologia Polska·2025

Same author

Sarcoidosis unmasked by Cushing's syndrome: successful surgical resolution.

Archives of medical science : AMS·2025

Same author

The position of monoclonal antibodies and small molecules in the treatment of thyroid orbitopathy.

Endokrynologia Polska·2025

Same author

Adrenal tumours and subclinical adrenal hyperfunction.

Endokrynologia Polska·2025

Search research articles

Related Experiment Video

Updated: Jul 5, 2026

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Published on: February 9, 2024

[Postpartum thyroiditis: current views on unappreciated disease].

Robert Krysiak¹, Bogdan Marek, Bogusław Okopień

¹Klinika Chorób Wewnetrznych i Farmakologii Klinicznej Katedry Farmakologii, Slaski Uniwersytet Medyczny, Katowice, Poland. r.krysiak@poczta.onet.pl

Endokrynologia Polska

|May 10, 2008

Summary

Postpartum thyroiditis, an autoimmune condition affecting 5-10% of women, can cause temporary or permanent thyroid dysfunction after childbirth. Early diagnosis and management are key for affected mothers.

Related Experiment Videos

Last Updated: Jul 5, 2026

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Published on: February 9, 2024

Area of Science:

Endocrinology
Immunology
Obstetrics

Context:

Postpartum thyroiditis (PPT) is an autoimmune thyroid disease occurring within the first year after childbirth.
It arises from immune system changes during and after pregnancy, affecting 5-10% of women.
PPT is linked to other autoimmune conditions and has a high recurrence rate (70%) in subsequent pregnancies.

Purpose:

To review the etiopathogenesis, clinical presentation, diagnostic criteria, prognosis, and treatment of postpartum thyroiditis.
To offer practical guidance for managing patients with this condition.

Summary:

Postpartum thyroiditis is characterized by an immune flare post-pregnancy, often associated with antithyroid peroxidase antibodies.
Patients may experience transient or permanent thyrotoxicosis or hypothyroidism, with hypothyroidism being more common and potentially lasting.
Diagnosis relies on abnormal thyroid function tests in postpartum women who are antithyroid peroxidase positive.

Impact:

Provides a comprehensive overview for healthcare professionals managing postpartum thyroiditis.
Highlights the importance of recognizing PPT's varied clinical course and diagnostic markers.
Aims to improve patient care through evidence-based guidance on prognosis and treatment.